Wuxi Beta Obtain C- 14 and H-3 Radiation Safety License
Release time:
2017-05-15
On May 15, 2017, Wuxi Beta Pharmaceutical Technology Co., Ltd. completed the construction of a non-sealed radioactive material workplace and obtained a C- 14 and H-3 radiation safety license. Wuxi Beta has been engaged in the simulation research and development of C14 labeled precursor compounds since 2009 and the cooperative research and development of C14 source materials since 2010. By October 2016, these tasks have been basically completed and a solid foundation for development has been established. At this time, the acquisition of radiation safety license marks the formal opening of China's professional C14 marking service.
On May 15, 2017, Wuxi Beta Pharmaceutical Technology Co., Ltd. completed the construction of a non-sealed radioactive material workplace and obtained a C- 14 and H-3 radiation safety license. Wuxi Beta has been engaged in the simulation research and development of C14 labeled precursor compounds since 2009 and the cooperative research and development of C14 source materials since 2010. By October 2016, these tasks have been basically completed and a solid foundation for development has been established. At this time, the acquisition of radiation safety license marks the formal opening of China's professional C14 marking service.
Related News
Tel.：0510-81695383
E-mail：chengcaihong@beitalab.com
Fax：0510-81602153
Add：70 Dongsheng West Road, Jiangyin City, Jiangsu Province
Postal Code: 214437
Copyright©2024 Wuxi Beita Pharmatech Co., Ltd. Business License
